Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol Injection for Postoperative Orthopedic Pain
CTR20231177Phase 2Completed
- Sponsor
- Huatai Chenguang Pharmaceutical
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tapentadol in postoperative pain, cancer pain, acute pain, chronic pain, sponsored by Huatai Chenguang Pharmaceutical. Started Apr 2023; status: completed.
02
Drugs
tapentadol
03
Conditions
postoperative paincancer painacute painchronic pain
Beyond the preview
Go deeper on CTR20231177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231177.